Quest for the right Drug

|
עמוד הבית / נורמיטן 25 / מידע מעלון לרופא

נורמיטן 25 NORMITEN 25 (ATENOLOL)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

פומי : PER OS

צורת מינון:

טבליה : TABLETS

Interactions : אינטראקציות

4.5 Interaction with other medicinal products and other forms of interaction
Combined use of beta blockers and calcium channel blockers with negative inotropic effects, e.g.
verapamil and diltiazem, can lead to an exaggeration of these effects particularly in patients with impaired ventricular function and/or sinoatrial or atrioventricular conduction abnormalities. This may result in severe hypotension, bradycardia and cardiac failure. Neither the beta blocker nor the calcium channel blocker should be administered intravenously within 48 hours of discontinuing the other.

Concomitant therapy with dihydropyridines, e.g. nifedipine, may increase the risk of hypotension, and cardiac failure may occur in patients with latent cardiac insufficiency.


Digitalis glycosides, in association with beta blockers, may increase atrioventricular conduction time.

Beta blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine. If the two drugs are co administered, the beta blocker should be withdrawn several days before discontinuing clonidine. If replacing clonidine by beta blocker therapy, the introduction of beta blockers should be delayed for several days after clonidine administration has stopped. (See also prescribing information for clonidine.)

Class I antiarrhythmic drugs (e.g. disopyramide) and amiodarone may have a potentiating effect on atrial-conduction time and induce negative inotropic effect.

Concomitant use of sympathomimetic agents, e.g. adrenaline (epinephrine), may counteract the effect of beta blockers.

Concomitant use with insulin and oral antidiabetic drugs may lead to the intensification of the blood sugar lowering effects of these drugs. Symptoms of hypoglycaemia, particularly tachycardia, may be masked (see section 4.4).

Concomitant use of prostaglandin synthetase inhibiting drugs, e.g. ibuprofen and indometacin, may decrease the hypotensive effects of beta blockers.

Caution must be exercised when using anaesthetic agents with Normiten. The anaesthetist should be informed and the choice of anaesthetic should be an agent with as little negative inotropic activity as possible. Use of beta blockers with anaesthetic drugs may result in attenuation of the reflex tachycardia and increase the risk of hypotension. Anaesthetic agents causing myocardial depression are best avoided.


שימוש לפי פנקס קופ''ח כללית 1994 Hypertension, angina pectoris, myocardial infarction
תאריך הכללה מקורי בסל 01/01/1995
הגבלות תרופה שאושרה לשימוש כללי בקופ'ח

בעל רישום

TEVA ISRAEL LTD

רישום

104 02 28834 01

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

01.11.21 - עלון לרופא

עלון מידע לצרכן

20.02.22 - עלון לצרכן אנגלית 20.02.22 - עלון לצרכן עברית 20.02.22 - עלון לצרכן ערבית 20.10.14 - החמרה לעלון 15.03.16 - החמרה לעלון 10.03.20 - החמרה לעלון 14.06.20 - החמרה לעלון 01.11.21 - החמרה לעלון

לתרופה במאגר משרד הבריאות

נורמיטן 25

קישורים נוספים

RxList WebMD Drugs.com